Roman Camarda
Principal Novo Holdings
Roman Camarda joined Venture Investments in 2022 as Senior Associate. Previous to that, Roman was a Vice President at Aquilo Capital Management where he focused on publicly traded biotech companies. Prior to Aquilo, Roman was Lead Translational Scientist at the Buck Institute where he worked with the business development office to create and incubate biotech start-ups.
Roman holds a PhD in Biomedical Sciences from University of California, San Francisco, and a BS in Biochemistry and BFA in Photomedia from University of Washington.
Seminars
Wednesday 27th January 2027
Panel Discussion: Where Are Investors Placing Their Bets Across Pain Therapeutics?
10:00 am
- Which pain targets, technologies and therapeutic approaches are attracting the greatest investment interest today?
- What data package is required to move a program from scientific promise to an investable opportunity?
- How are investors assessing technical, clinical and commercial risk in an increasingly competitive pain landscape?
- Where do investors see the biggest opportunities and unmet needs shaping the next wave of pain innovation?
